Continuing Education

 


Continuing education credits are jointly provided by Postgraduate Institute for Medicine (PIM) and the Alzheimer’s Association.

Expiration: June 15, 2023

On This Page:

Target Audience

This activity is intended for biochemists, geriatric psychiatrists, geriatric specialists, molecular and cell biologists, neurologists, neuroscientists, nurses, pharmacologists, primary care physicians, psychiatrists, psychologists, radiologists and social workers involved in the research and/or care of people with Alzheimer’s and other dementias.

Educational Objectives

After completing this activity, the participant should be better able to:

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine (PIM) and the Alzheimer’s Association. PIM is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

PIM designates this live activity for a maximum of 23.75 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Psychology Sponsorship Statement

PIM is approved by the American Psychological Association to sponsor continuing education for psychologists. PIM maintains responsibility for this program and its content. This program offers 18.75 continuing education credits for psychologists.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 23.75 contact hours.

Social Worker Education

As a Jointly Accredited Organization, PIM is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. PIM maintains responsibility for this course. Social workers completing this course receive 23.75 clinical continuing education credits.

Disclosure of Conflicts of Interest

PIM requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

A copy of the Speaker Disclosure of Conflicts of Interest report is available at the Continuing Education kiosk at on-site registration.

The Alzheimer’s Association and PIM planners and others have nothing to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information and comparison with recommendations of other authorities.

How to Claim Credit

Please email nsanders@alz.org with questions.



Become an ISTAART Member

Go beyond the conference — Network and collaborate year-round with a global community of leaders who are working to advance Alzheimer’s and dementia research.


JOIN ISTAART

Join the Conversation #AAIC22

Follow

Exhibitors

Exhibitors

Sponsors

Sponsorship

News & Videos

Press Room

Contact Us

> 1200px
lg
> 992px
md
> 768px
sm
< 767px
xs